阿拉丁 |
P127815-5mg |
5mg |
现货 |
802539-81-7 |
PHA-848125,ATP竞争性CDK2和TRKA抑制... PHA-848125 |
≥98% |
574.90
574.90
|
|
阿拉丁 |
P127815-10mg |
10mg |
现货 |
802539-81-7 |
PHA-848125,ATP竞争性CDK2和TRKA抑制... PHA-848125 |
≥98% |
638.90
638.90
|
|
阿拉丁 |
P127815-50mg |
50mg |
现货 |
802539-81-7 |
PHA-848125,ATP竞争性CDK2和TRKA抑制... PHA-848125 |
≥98% |
1,736.90
1,736.90
|
|
阿拉丁 |
P127815-1mg |
1mg |
现货 |
802539-81-7 |
PHA-848125,ATP竞争性CDK2和TRKA抑制... PHA-848125 |
≥98% |
487.90
487.90
|
|
阿拉丁 |
M409217-1ml |
1ml |
现货 |
802539-81-7 |
Milciclib (PHA-848125) Milciclib (PHA-848125) |
10mM in DMSO |
1,723.90
1,723.90
|
|
罗恩 |
R026175-1mg |
1mg |
5~7个工作日 |
802539-81-7 |
4,5-二氢-n,1,4,4-四甲基-8-[[4-(4-... PHA-848125 |
99% |
477.00
477.00
|
|
麦克林 |
M872436-1mg |
1mg |
咨询客服 |
802539-81-7 |
Milciclib (PHA-848125) Milciclib (PHA-848125) |
99% |
1,113.00
1,113.00
|
|
毕得 |
BD211339-1mg |
1mg |
现货 |
802539-81-7 |
N,1,4,4-四甲基-8-((4-(4-甲基哌嗪-1-... N,1,4,4-Tetramethyl-8-((4-(4... |
98+% |
126.00
126.00
|
|
毕得 |
BD211339-25mg |
25mg |
现货 |
802539-81-7 |
N,1,4,4-四甲基-8-((4-(4-甲基哌嗪-1-... N,1,4,4-Tetramethyl-8-((4-(4... |
98+% |
1,086.00
1,086.00
|
|
毕得 |
BD211339-5mg |
5mg |
现货 |
802539-81-7 |
N,1,4,4-四甲基-8-((4-(4-甲基哌嗪-1-... N,1,4,4-Tetramethyl-8-((4-(4... |
98+% |
376.00
376.00
|
|
毕得 |
BD211339-10mg |
10mg |
现货 |
802539-81-7 |
N,1,4,4-四甲基-8-((4-(4-甲基哌嗪-1-... N,1,4,4-Tetramethyl-8-((4-(4... |
98+% |
639.00
639.00
|
|
毕得 |
BD211339-50mg |
50mg |
现货 |
802539-81-7 |
N,1,4,4-四甲基-8-((4-(4-甲基哌嗪-1-... N,1,4,4-Tetramethyl-8-((4-(4... |
98+% |
1,737.00
1,737.00
|
|
毕得 |
BD211339-100mg |
100mg |
现货 |
802539-81-7 |
N,1,4,4-四甲基-8-((4-(4-甲基哌嗪-1-... N,1,4,4-Tetramethyl-8-((4-(4... |
98+% |
2,778.00
2,778.00
|
|
毕得 |
BD211339-250mg |
250mg |
现货 |
802539-81-7 |
N,1,4,4-四甲基-8-((4-(4-甲基哌嗪-1-... N,1,4,4-Tetramethyl-8-((4-(4... |
98+% |
4,722.00
4,722.00
|
|